Sen­a­tors ques­tion how HHS plans to roll out new drug pric­ing re­forms

While CMS drug price ne­go­ti­a­tions won’t ac­tu­al­ly kick off un­til 2026, a group of more than two dozen Re­pub­li­can sen­a­tors is al­ready rais­ing ques­tions about how this new law will be im­ple­ment­ed.

The par­ti­san law (all De­moc­rats in the House and Sen­ate vot­ed for it, and all Re­pub­li­cans vot­ed against it) in­cludes not on­ly Medicare price ne­go­ti­a­tions but manda­to­ry in­fla­tion-re­lat­ed re­bates that will be­gin next year, as well as mil­lion-dol­lar fines for non­com­pli­ance.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.